The global immunoassay market is projected to reach USD 32.79 billion by 2028, growing at a CAGR of 5.8%. Increasing occurrence of chronic and infectious diseases, progression in the biotechnology and biopharmaceutical businesses and increasing implementation of point-of-care (POC) testing products are some of the factors driving the growth of the global immunoassay market.

Adroit Market Research report on global Immunoassay market gives a holistic view of the market from 2018 to 2028, which includes factors such as market drivers, restraints, opportunities and challenges. The market has been studied for historic years from 2018 to 2019, with the base year of estimation as 2020 and forecast from 2021 to 2028. The report covers the current status and future traits of the market at global as well as country level. In addition, the study also assesses the key players based on their product portfolio, geographic footprint, strategic initiatives and overall revenue. Prominent players operating in the global immunoassay market have been studied in detail.

The global immunoassay market is categorized based on product, technology, application and end-use. On the basis of product, the market is segmented into reagents and kits, analyzers, and software and services. The reagents and kits dominated the market in 2020. On the basis of technology, the market is segmented into radioimmunoassay, enzyme immunoassay, rapid test and others. By application, the market is segmented into therapeutic drug monitoring, oncology, cardiology, endocrinology, infectious disease testing, autoimmune diseases and others. In 2020, the infectious disease testing accounted for the largest share of the global immunoassay market.

North America dominated the market for immunoassay in 2020, while Asia-Pacific is set to grow at the highest CAGR due to improved approval of medical devices. Key players of the global immunoassay market include Siemens Healthineers, BioMérieux, Becton, Dickinson & Company, Abbott laboratories, Danaher Corporation, Roche Diagnostics, Ortho Clinical Diagnostics, Thermo Fisher Scientific, Inc., Sysmex Corporation, Quidel Corporation among others.

Key segments of the global immunoassay market

Technology Overview, 2018-2028 (USD Billion)

• Radioimmunoassay
• Enzyme immunoassay
• Rapid test
• Others

Product Overview, 2018-2028 (USD Billion)

• Reagents & kits
• Analyzers
• Software & services

Application Overview, 2018-2028 (USD Billion)

• Therapeutic drug monitoring
• Oncology
• Cardiology
• Endocrinology
• Infectious disease testing
• Autoimmune diseases
• Others

End User Overview, 2018-2028 (USD Billion)

• Hospitals
• Blood banks
• Clinical laboratories
• Pharmaceutical and biotech companies
• Academic research centers
• Others

Regional Overview, 2018-2028 (USD Billion)

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • United Kingdom
  • France
• Asia Pacific
  • China
  • Japan
  • India
• South America
  • Brazil
  • Mexico
• Middle East & Africa
  • GCC
  • South Africa